nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—cardiovascular system—metabolic syndrome X	0.0126	0.136	CbGeAlD
Trametinib—MAP2K1—kidney—metabolic syndrome X	0.0123	0.133	CbGeAlD
Trametinib—MAP2K1—adipose tissue—metabolic syndrome X	0.0111	0.12	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—metabolic syndrome X	0.0111	0.12	CbGeAlD
Trametinib—MAP2K2—kidney—metabolic syndrome X	0.0109	0.117	CbGeAlD
Trametinib—MAP2K2—adipose tissue—metabolic syndrome X	0.0098	0.105	CbGeAlD
Trametinib—MAP2K1—liver—metabolic syndrome X	0.0078	0.084	CbGeAlD
Trametinib—MAP2K2—liver—metabolic syndrome X	0.00687	0.074	CbGeAlD
Trametinib—CYP2C8—kidney—metabolic syndrome X	0.00376	0.0405	CbGeAlD
Trametinib—Pain in extremity—Metformin—metabolic syndrome X	0.00349	0.0395	CcSEcCtD
Trametinib—Dehydration—Metformin—metabolic syndrome X	0.00324	0.0368	CcSEcCtD
Trametinib—Abdominal pain upper—Metformin—metabolic syndrome X	0.00319	0.0361	CcSEcCtD
Trametinib—Pancreatitis—Metformin—metabolic syndrome X	0.00296	0.0335	CcSEcCtD
Trametinib—Abdominal discomfort—Metformin—metabolic syndrome X	0.00289	0.0328	CcSEcCtD
Trametinib—Neutropenia—Metformin—metabolic syndrome X	0.00282	0.0319	CcSEcCtD
Trametinib—Infestation NOS—Metformin—metabolic syndrome X	0.00269	0.0305	CcSEcCtD
Trametinib—Infestation—Metformin—metabolic syndrome X	0.00269	0.0305	CcSEcCtD
Trametinib—CYP3A4—kidney—metabolic syndrome X	0.00255	0.0275	CbGeAlD
Trametinib—Bradycardia—Metformin—metabolic syndrome X	0.00246	0.0278	CcSEcCtD
Trametinib—CYP2C8—liver—metabolic syndrome X	0.00238	0.0256	CbGeAlD
Trametinib—Oedema peripheral—Metformin—metabolic syndrome X	0.00238	0.0269	CcSEcCtD
Trametinib—Connective tissue disorder—Metformin—metabolic syndrome X	0.00237	0.0269	CcSEcCtD
Trametinib—Eye disorder—Metformin—metabolic syndrome X	0.00225	0.0256	CcSEcCtD
Trametinib—Cardiac disorder—Metformin—metabolic syndrome X	0.00224	0.0254	CcSEcCtD
Trametinib—Angiopathy—Metformin—metabolic syndrome X	0.00219	0.0248	CcSEcCtD
Trametinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.00217	0.0246	CcSEcCtD
Trametinib—Chills—Metformin—metabolic syndrome X	0.00216	0.0245	CcSEcCtD
Trametinib—Malnutrition—Metformin—metabolic syndrome X	0.0021	0.0238	CcSEcCtD
Trametinib—Erythema—Metformin—metabolic syndrome X	0.0021	0.0238	CcSEcCtD
Trametinib—Dysgeusia—Metformin—metabolic syndrome X	0.00206	0.0233	CcSEcCtD
Trametinib—Muscle spasms—Metformin—metabolic syndrome X	0.00202	0.0229	CcSEcCtD
Trametinib—Vision blurred—Metformin—metabolic syndrome X	0.00198	0.0224	CcSEcCtD
Trametinib—Hypertension—Metformin—metabolic syndrome X	0.00181	0.0206	CcSEcCtD
Trametinib—Myalgia—Metformin—metabolic syndrome X	0.00179	0.0203	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00178	0.0201	CcSEcCtD
Trametinib—Oedema—Metformin—metabolic syndrome X	0.00171	0.0194	CcSEcCtD
Trametinib—Infection—Metformin—metabolic syndrome X	0.0017	0.0193	CcSEcCtD
Trametinib—Nervous system disorder—Metformin—metabolic syndrome X	0.00168	0.0191	CcSEcCtD
Trametinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.00168	0.019	CcSEcCtD
Trametinib—Skin disorder—Metformin—metabolic syndrome X	0.00166	0.0189	CcSEcCtD
Trametinib—Hyperhidrosis—Metformin—metabolic syndrome X	0.00166	0.0188	CcSEcCtD
Trametinib—CYP3A4—liver—metabolic syndrome X	0.00161	0.0174	CbGeAlD
Trametinib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00156	0.0177	CcSEcCtD
Trametinib—Decreased appetite—Metformin—metabolic syndrome X	0.00149	0.0169	CcSEcCtD
Trametinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00148	0.0168	CcSEcCtD
Trametinib—Fatigue—Metformin—metabolic syndrome X	0.00148	0.0167	CcSEcCtD
Trametinib—Constipation—Metformin—metabolic syndrome X	0.00147	0.0166	CcSEcCtD
Trametinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0014	0.0159	CcSEcCtD
Trametinib—Abdominal pain—Metformin—metabolic syndrome X	0.00136	0.0154	CcSEcCtD
Trametinib—Asthenia—Metformin—metabolic syndrome X	0.00123	0.0139	CcSEcCtD
Trametinib—Pruritus—Metformin—metabolic syndrome X	0.00121	0.0137	CcSEcCtD
Trametinib—Diarrhoea—Metformin—metabolic syndrome X	0.00117	0.0133	CcSEcCtD
Trametinib—Dizziness—Metformin—metabolic syndrome X	0.00113	0.0128	CcSEcCtD
Trametinib—Vomiting—Metformin—metabolic syndrome X	0.00109	0.0124	CcSEcCtD
Trametinib—Rash—Metformin—metabolic syndrome X	0.00108	0.0122	CcSEcCtD
Trametinib—Dermatitis—Metformin—metabolic syndrome X	0.00108	0.0122	CcSEcCtD
Trametinib—Headache—Metformin—metabolic syndrome X	0.00107	0.0122	CcSEcCtD
Trametinib—Nausea—Metformin—metabolic syndrome X	0.00102	0.0115	CcSEcCtD
Trametinib—MAP2K2—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000255	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000255	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—AKT1—metabolic syndrome X	0.000255	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—AKT1—metabolic syndrome X	0.000255	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	0.000254	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—AKT1—metabolic syndrome X	0.000254	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—metabolic syndrome X	0.000253	0.000309	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—AKT1—metabolic syndrome X	0.000253	0.000309	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.00025	0.000306	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—AKT1—metabolic syndrome X	0.000249	0.000304	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—AKT1—metabolic syndrome X	0.000249	0.000304	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000247	0.000302	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT2—metabolic syndrome X	0.000247	0.000301	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CYBA—metabolic syndrome X	0.000246	0.0003	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000245	0.000299	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000244	0.000298	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—AKT1—metabolic syndrome X	0.000241	0.000294	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.00024	0.000293	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IRS1—metabolic syndrome X	0.00024	0.000293	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—AKT1—metabolic syndrome X	0.000239	0.000291	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000239	0.000291	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000239	0.000291	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000238	0.00029	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RBP4—metabolic syndrome X	0.000238	0.00029	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000237	0.000289	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—AKT1—metabolic syndrome X	0.000236	0.000289	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SLC2A4—metabolic syndrome X	0.000235	0.000287	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.000234	0.000286	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000234	0.000285	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—AKT1—metabolic syndrome X	0.000233	0.000285	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	0.000233	0.000284	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	0.000233	0.000284	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—VCAM1—metabolic syndrome X	0.000231	0.000282	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000229	0.00028	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000228	0.000279	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GOT1—metabolic syndrome X	0.000228	0.000278	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000226	0.000276	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—AKT1—metabolic syndrome X	0.000225	0.000275	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000224	0.000274	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000224	0.000273	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000223	0.000272	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000222	0.000271	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RBP4—metabolic syndrome X	0.000222	0.000271	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000221	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC2A4—metabolic syndrome X	0.00022	0.000269	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	0.000219	0.000267	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—VCAM1—metabolic syndrome X	0.000216	0.000264	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GOT1—metabolic syndrome X	0.000213	0.00026	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000211	0.000258	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOC3—metabolic syndrome X	0.00021	0.000257	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000209	0.000256	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000208	0.000255	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000208	0.000254	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL18—metabolic syndrome X	0.000204	0.00025	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000202	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOC3—metabolic syndrome X	0.000197	0.00024	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOB—metabolic syndrome X	0.000193	0.000236	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	0.000191	0.000234	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL18—metabolic syndrome X	0.000191	0.000234	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00019	0.000232	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD36—metabolic syndrome X	0.00019	0.000232	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—metabolic syndrome X	0.000188	0.00023	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AGT—metabolic syndrome X	0.000187	0.000229	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—FABP4—metabolic syndrome X	0.000186	0.000227	CbGpPWpGaD
Trametinib—MAP2K2—Disease—LPL—metabolic syndrome X	0.000185	0.000225	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CYBA—metabolic syndrome X	0.000184	0.000225	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOB—metabolic syndrome X	0.000181	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GHRL—metabolic syndrome X	0.00018	0.00022	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	0.000179	0.000219	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000178	0.000217	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD36—metabolic syndrome X	0.000178	0.000217	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	0.000177	0.000216	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—metabolic syndrome X	0.000176	0.000215	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AGT—metabolic syndrome X	0.000175	0.000214	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—metabolic syndrome X	0.000174	0.000212	CbGpPWpGaD
Trametinib—MAP2K1—Disease—LPL—metabolic syndrome X	0.000173	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CYBA—metabolic syndrome X	0.000172	0.00021	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—metabolic syndrome X	0.000171	0.000209	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000171	0.000209	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CNR1—metabolic syndrome X	0.000171	0.000208	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—metabolic syndrome X	0.00017	0.000208	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GHRL—metabolic syndrome X	0.000168	0.000206	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000166	0.000203	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000163	0.000199	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—metabolic syndrome X	0.000162	0.000198	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—metabolic syndrome X	0.000161	0.000197	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—metabolic syndrome X	0.00016	0.000196	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CNR1—metabolic syndrome X	0.00016	0.000195	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—metabolic syndrome X	0.000159	0.000195	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000157	0.000192	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000155	0.00019	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—metabolic syndrome X	0.000155	0.000189	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000154	0.000188	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.000154	0.000188	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOA1—metabolic syndrome X	0.000153	0.000187	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—metabolic syndrome X	0.000151	0.000184	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—metabolic syndrome X	0.000151	0.000184	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.00015	0.000183	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.00015	0.000183	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IRS1—metabolic syndrome X	0.000149	0.000182	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.000145	0.000177	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—metabolic syndrome X	0.000145	0.000177	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000144	0.000176	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000144	0.000176	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.000144	0.000176	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOA1—metabolic syndrome X	0.000143	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—metabolic syndrome X	0.000141	0.000172	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.00014	0.000171	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IRS1—metabolic syndrome X	0.00014	0.000171	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.00014	0.000171	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF2—metabolic syndrome X	0.000139	0.00017	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IRS1—metabolic syndrome X	0.000138	0.000168	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000137	0.000167	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000135	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOB—metabolic syndrome X	0.000135	0.000165	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	0.000134	0.000163	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL5—metabolic syndrome X	0.000132	0.000161	CbGpPWpGaD
Trametinib—MAP2K2—Disease—INS—metabolic syndrome X	0.000132	0.000161	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000132	0.000161	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—metabolic syndrome X	0.00013	0.000159	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LPL—metabolic syndrome X	0.000129	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IRS1—metabolic syndrome X	0.000129	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOB—metabolic syndrome X	0.000127	0.000155	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000125	0.000153	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000125	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL5—metabolic syndrome X	0.000124	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—Disease—INS—metabolic syndrome X	0.000124	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000123	0.00015	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—metabolic syndrome X	0.000122	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SERPINE1—metabolic syndrome X	0.000121	0.000148	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LPL—metabolic syndrome X	0.000121	0.000148	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	0.00012	0.000147	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000119	0.000146	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LIPC—metabolic syndrome X	0.000119	0.000146	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCK—metabolic syndrome X	0.000119	0.000146	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOC3—metabolic syndrome X	0.000118	0.000145	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000118	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—metabolic syndrome X	0.000116	0.000142	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CETP—metabolic syndrome X	0.000115	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—metabolic syndrome X	0.000114	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—metabolic syndrome X	0.000114	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—metabolic syndrome X	0.000112	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AGT—metabolic syndrome X	0.000111	0.000135	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	0.00011	0.000135	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—metabolic syndrome X	0.000108	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—metabolic syndrome X	0.000108	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—metabolic syndrome X	0.000108	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—metabolic syndrome X	0.000107	0.000131	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000107	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—metabolic syndrome X	0.000107	0.000131	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	0.000107	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—metabolic syndrome X	0.000106	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—metabolic syndrome X	0.000105	0.000128	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	0.000104	0.000127	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—metabolic syndrome X	0.000104	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—metabolic syndrome X	0.000103	0.000126	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—metabolic syndrome X	0.000101	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—metabolic syndrome X	0.000101	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—metabolic syndrome X	0.0001	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—metabolic syndrome X	0.0001	0.000122	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	9.99e-05	0.000122	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—metabolic syndrome X	9.92e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—metabolic syndrome X	9.91e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS1—metabolic syndrome X	9.66e-05	0.000118	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	9.47e-05	0.000116	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.38e-05	0.000115	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	9.27e-05	0.000113	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	9.27e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—metabolic syndrome X	9.27e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—metabolic syndrome X	9.25e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—metabolic syndrome X	9.1e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS1—metabolic syndrome X	9.04e-05	0.00011	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—metabolic syndrome X	8.98e-05	0.00011	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT1—metabolic syndrome X	8.98e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—metabolic syndrome X	8.95e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—metabolic syndrome X	8.66e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—metabolic syndrome X	8.52e-05	0.000104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.5e-05	0.000104	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	8.44e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—metabolic syndrome X	8.37e-05	0.000102	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	8.24e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—metabolic syndrome X	8.11e-05	9.91e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	8.06e-05	9.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	8.06e-05	9.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.95e-05	9.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	7.8e-05	9.53e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	7.72e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—metabolic syndrome X	7.66e-05	9.36e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOB—metabolic syndrome X	7.62e-05	9.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—metabolic syndrome X	7.59e-05	9.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	7.41e-05	9.05e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—metabolic syndrome X	7.28e-05	8.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	7.18e-05	8.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—metabolic syndrome X	7.17e-05	8.75e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—metabolic syndrome X	6.91e-05	8.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—metabolic syndrome X	6.84e-05	8.36e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.44e-05	7.86e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—metabolic syndrome X	6.43e-05	7.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—metabolic syndrome X	6.4e-05	7.82e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.4e-05	7.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.4e-05	7.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.36e-05	7.77e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—metabolic syndrome X	6.31e-05	7.71e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—metabolic syndrome X	6.25e-05	7.64e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—metabolic syndrome X	6.22e-05	7.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	6.17e-05	7.54e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—metabolic syndrome X	6.1e-05	7.45e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—metabolic syndrome X	6.03e-05	7.36e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.91e-05	7.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—metabolic syndrome X	5.91e-05	7.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—metabolic syndrome X	5.85e-05	7.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—metabolic syndrome X	5.77e-05	7.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—metabolic syndrome X	5.77e-05	7.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.74e-05	7.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.58e-05	6.82e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.58e-05	6.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—metabolic syndrome X	5.4e-05	6.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—metabolic syndrome X	5.4e-05	6.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—metabolic syndrome X	5.37e-05	6.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—metabolic syndrome X	5.33e-05	6.5e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—metabolic syndrome X	5.31e-05	6.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—metabolic syndrome X	5.21e-05	6.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—metabolic syndrome X	5.02e-05	6.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—metabolic syndrome X	4.98e-05	6.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.98e-05	6.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.98e-05	6.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.82e-05	5.89e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.82e-05	5.89e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—metabolic syndrome X	4.78e-05	5.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—metabolic syndrome X	4.57e-05	5.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	4.18e-05	5.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	4.09e-05	4.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—metabolic syndrome X	4.04e-05	4.94e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.98e-05	4.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.91e-05	4.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—metabolic syndrome X	3.78e-05	4.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—metabolic syndrome X	3.73e-05	4.55e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.71e-05	4.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—metabolic syndrome X	3.49e-05	4.26e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.45e-05	4.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.34e-05	4.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.27e-05	4e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.24e-05	3.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.85e-05	3.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—metabolic syndrome X	2.8e-05	3.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.56e-05	3.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.45e-05	2.99e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.24e-05	2.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—metabolic syndrome X	2.1e-05	2.56e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.13e-05	1.38e-05	CbGpPWpGaD
